ConversationAdam Lange My name is Adam Lange. I'm the Head of Investor Relations. And on behalf of the entire Zealand Pharma team, we are very pleased to see so many of you today. Thanks a lot for spending the next few hours with us. Today, it is exactly -- almost exactly 2 years ago since we did our last Capital Markets event, our obesity R&D event in December 2023, where for the first time, at least towards a broader audience of investors and analysts, we really articulated the ambition of Zealand Pharma ...

Early trading suggests the cable-network spinoff is being valued conservatively, a signal that could matter in the Warner Bros. Discovery takeover battle. ...

If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose goal is to discover investment opportunities in the aerospace, defense and airline industry. With a background in aeros ...

Can this rally be sustained. Well, I think you have to kind of stand back and look at the bigger picture. You know, the rally that we saw, for instance, in the late seventies and early eighties was something that was, you know, remarkable at the time.But if you look at today's rally and comparison, you know, it's still barely a scratch on that. I'm not obviously saying that necessarily it's going to go to the same extremes. We're already ahead of it in nominal terms.But in terms of when it's a regime shift, ...

By Milana Vinn Dec 15 (Reuters) - Goldman Sachs is restructuring its influential technology, media, and telecom (TMT) investment banking group with an eye ​toward infrastructure deals and artificial intelligence, creating two new teams ‌with new leaders, according to the internal memo seen by Reuters. The bank is combining its ‌telecom and "CoreTech" teams to form a new Global Infrastructure Technology sector. The unit will be co-headed by partners Yasmine Coupal and Jason Tofsky. Coupal, a partner sinc ...

Goldman Sachs is restructuring its influential technology, media, and telecom (TMT) investment banking group with an eye toward infrastructure deals and artificial intelligence, creating two new teams... ...

The pendulum often swings too far, and in both directions. That appears to be happening with Oracle Corporation ( ORCL ). In hindsight, the stock experienced irrational exuberance following the booking of strong commitments from OpenAI. This ledJulian Lin is a financial analyst. He finds undervalued companies with secular growth that appreciate over time. His approach is to look for companies with strong balance sheets and management teams in sectors with long growth runways. Julian is the leader of the inv ...

An options strategy called a "box spread" is gaining steam by the billions as an alternative to Treasury bills and traditional loans. The tactic gets its name from the four-sided structure of options trades that simultaneously bet on calls and puts at strike prices for securities at a reliable spread. Potential tax and lending advantages are driving the appeal of box spreads, according to Brent Sullivan, a consultant on product distribution to sub-advisory and ETF firms. He's the author of the Tax Alpha I ...

NEW YORK, Dec. 15, 2025 /PRNewswire/ --The Board of Directors of The Taiwan Fund, Inc. (NYSE: TWN) (the "Fund") has declared capital gain and net investment income distributions in the aggregate amount of $6.2002 per share. The capital gain portion of the distributions is comprised of long-term capital gains of $6.0873 per share and the short-term capital gain of $0.0751 per share. The net investment income portion of the distributions is $0.0378 per share. The distribution will be payable on January 06, 2 ...

President Donald Trump said on Monday he is considering signing an executive order to reclassify marijuana as a less dangerous drug. ...